Not Declining—Transforming: The New Era of Drug Use

“Absolutely frightening.” “Horror stats.” “Out of control”. “Silent epidemic”.
The language is dramatic, but the shift is real.

Across England and Wales, experts warn urology departments are nearing breaking point as ketamine-related hospital admissions surge. This isn’t a spike, it’s a pattern. Drug use isn’t fading. It’s evolving.

History shows the trend. Cocaine once found its way into early soft drinks like Coca-Cola. Psychedelics defined parts of the 1960s flare. Now, the spotlight turns to ketamine.

Originally developed as a medical anesthetic, used for pain management and even treatment-resistant depression, ketamine has legitimate clinical value. But outside controlled settings, its hallucinogenic and dissociative effects make it a very different proposition.

Today, it’s no longer confined to niche club scenes. Reports suggest use among children as young as 12. What was once fringe is now edging toward the mainstream.

So why does this matter at work?

Because those headlines don’t stay in the news cycle. They walk into the workplace.

Ketamine can impair coordination, slow reaction times, and distort perception. In safety-critical environments, that’s not just a personal issue—it’s a direct operational risk.

And unlike traditional substances, ketamine can be harder to spot through behaviour alone. That makes prevention and detection more complex, and more important.

This is where structured support matters.

OdiliaClark offers:

• Drug and alcohol testing, including emerging substances
• Workplace policy development to protect both employers and employees
• Peer Support and Wellbeing Services

As drug trends shift, organisations can’t rely on outdated assumptions. The new era demands proactive strategies, because what’s changing outside the workplace doesn’t stay there.